About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Belgian Registry on Coronary Function Testing | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT06089031

Belgian Registry on Coronary Function Testing

The goal of this prospective, multicenter registy is to describe the 'real-world' use of coronary function tests, which may consist of bolus thermodilution measurements of coronary microvascular funct...

Lead sponsor: University Hospital, Antwerp•13 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital, Antwerp

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patient scheduled for coronary function test, comprising of intracoronary bolus thermodilution measurements of microvascular function, and/or intracoronary vasoreactivity tests with acetylcholine.
•Subject understands the study requirements and provides written informed consent.

Exclusion Criteria

•Subject is participating in another investigational clinical trial that may cause non-compliance with the protocol or confound data interpretation.
•Subject intends to participate in another investigational clinical trial that may cause non-compliance with the protocol or confound data interpretation.
•Documented or suspected pregnancy.
•Inability to provide written informed consent.

Related studies

A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

NCT07093528 · Heart Failure With Preserved Ejection Fraction, Coronary Microvascular Dysfunction

Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)

NCT06991322 · Coronary Microvascular Dysfunction, Coronary Microvascular Disease

RECRUITINGPhase 4

A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.

NCT05984537 · Coronary Microvascular Dysfunction

Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution

NCT06795035 · ST Elevation Myocardial Infarction, Coronary Microvascular Dysfunction, and more

Insulin Resistance and Coronary Microvascular Dysfunction in Patients with Myocardial Ischemia and Non-obstructive Coronary Artery Disease

NCT06597851 · Coronary Microvascular Dysfunction, Coronary Microvascular Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 18, 2023Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment650

Start dateOct 2021

Last updatedOct 18, 2023

Condition

Coronary Microvascular Dysfunction Coronary Artery Vasospasm

Locations shown

AZ Monica

Deurne, Antwerp

AZ Sint-Maarten

Mechelen, Antwerp

Jessa Hasselt

Hasselt, Limburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 18, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions